Anti-Sm

Anti-Smith Antibodies

Otros

Última revisión: 7 de abril de 2026. Enfoque de fuentes: contexto estándar de interpretación de laboratorio, material médico de referencia y orientación clínica o de salud pública cuando corresponde.

¿Qué es Anti-Smith Antibodies?

Anti-Smith (anti-Sm) antibodies are autoantibodies directed against the Smith antigen, a complex of small nuclear ribonucleoproteins (snRNPs) involved in RNA splicing within the cell nucleus. These antibodies are named after Stephanie Smith, the patient in whom they were first identified. Anti-Sm antibodies target specific proteins (B/B', D1, D2, D3, E, F, and G) that form the core of the spliceosomal snRNP complex, a structure essential for processing precursor messenger RNA (pre-mRNA) into mature mRNA.

Anti-Smith antibodies are highly specific for systemic lupus erythematosus (SLE) and are included in the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for the disease. While they are found in only 20–30% of SLE patients overall (with higher prevalence in African American and Asian populations), their presence is virtually diagnostic—anti-Sm antibodies are rarely if ever found in other autoimmune diseases or healthy individuals. This makes them one of the most specific serological markers for lupus, alongside anti-double-stranded DNA (anti-dsDNA) antibodies.

Por qué importa

Anti-Smith antibodies are among the most specific markers for systemic lupus erythematosus, with a specificity approaching 99%. While their sensitivity is limited (present in only 20–30% of SLE patients), a positive result essentially confirms the diagnosis of lupus when clinical features are consistent. Unlike anti-dsDNA antibodies, which fluctuate with disease activity, anti-Sm antibodies tend to remain positive regardless of disease activity once they appear, making them useful for diagnosis but less helpful for monitoring flares. Some studies suggest that anti-Sm positivity correlates with renal involvement (lupus nephritis) and central nervous system disease, though this association is debated.

Rangos de referencia normales

Grupo	Rango	Unidad
Negative	<1.0	AI (antibody index)
Equivocal	1.0–1.5	AI
Positive	>1.5	AI

Los rangos de referencia pueden variar entre laboratorios. Compara siempre tus resultados con los rangos proporcionados por tu laboratorio.

Qué significan los niveles altos de Anti-Sm

Causas comunes

Systemic lupus erythematosus (SLE)—highly specific
Overlap connective tissue disease (rarely)
Mixed connective tissue disease (uncommon)

Posibles síntomas

Joint pain and swelling (arthralgia, arthritis)
Butterfly rash (malar rash) across cheeks and nose
Photosensitivity
Fatigue and malaise
Oral ulcers
Pleurisy or pericarditis
Kidney involvement (proteinuria, hematuria)
Cytopenias (low blood counts)

Qué hacer: A positive anti-Sm result in a patient with compatible symptoms strongly supports SLE diagnosis. Referral to rheumatology is essential. Additional workup should include ANA, anti-dsDNA, complement levels (C3, C4), complete blood count, urinalysis, and renal function tests. Treatment depends on organ involvement and disease severity, ranging from hydroxychloroquine for mild disease to immunosuppressive agents (mycophenolate, cyclophosphamide) and biologics (belimumab) for severe manifestations.

Qué significan los niveles bajos de Anti-Sm

Causas comunes

Normal finding—most healthy people and non-lupus patients are negative
SLE without anti-Sm antibodies (70–80% of SLE patients are anti-Sm negative)

Posibles síntomas

No symptoms—a negative result is expected in healthy individuals

Qué hacer: A negative anti-Sm result does not rule out SLE, as 70–80% of lupus patients are anti-Sm negative. If SLE is clinically suspected despite negative anti-Sm, evaluate other lupus-specific antibodies (anti-dsDNA, anti-Ro, anti-La, anti-RNP), ANA pattern, and complement levels. Clinical criteria should guide diagnosis.

¿Cuándo se recomienda la prueba de Anti-Sm?

When systemic lupus erythematosus is suspected
As part of an autoimmune antibody panel (ANA, anti-dsDNA, ENA panel)
When a positive ANA requires further characterization
In patients with lupus-like symptoms and negative anti-dsDNA
To support SLE classification criteria

Preguntas frecuentes

False-positive anti-Sm results are extremely rare. Anti-Smith antibodies have near 99% specificity for SLE, meaning that a positive result almost always indicates lupus. In very rare cases, low-titer positive results may be found in other autoimmune conditions, but these are uncommon enough that a positive anti-Sm should be considered highly suggestive of SLE until proven otherwise. If the result is equivocal, repeating the test or using a different assay method (immunoblot, ELISA) may help clarify.

Unlike anti-dsDNA antibodies, which tend to rise during lupus flares and fall during remission, anti-Sm antibodies generally remain relatively stable over time once they become positive. They do not reliably track with disease activity and should not be used to monitor flare status. For monitoring SLE activity, anti-dsDNA titers, complement levels (C3, C4), and clinical assessment are more useful. Anti-Sm is best used as a diagnostic marker rather than a monitoring tool.

Anti-Smith antibodies are found in approximately 30–40% of African American SLE patients and 30–50% of Asian SLE patients, compared to only 10–20% of Caucasian SLE patients. The reasons for this disparity are not fully understood but likely involve genetic factors affecting immune regulation, HLA haplotype distribution, and differences in lupus phenotype across populations. African American and Asian patients with SLE also tend to have more severe disease overall, including higher rates of lupus nephritis, which has been associated with anti-Sm positivity in some studies.

Biomarcadores relacionados

C3Complement C3 C4Complement C4

Referencias y enfoque de revisión

Las páginas del glosario de biomarcadores son explicaciones educativas y deben interpretarse junto con los rangos de referencia y comentarios proporcionados por tu laboratorio y tu profesional de salud. Para conocer nuestros estándares editoriales y proceso de revisión, consulta nuestra Política editorial y nuestro Proceso de revisión de contenido.

¿Quieres analizar tus niveles de Anti-Sm?

Sube tus resultados de laboratorio para recibir un análisis instantáneo con IA de todos tus biomarcadores.

Subir resultados de laboratorio →

Aviso médico: Esta información es solo educativa y no sustituye el consejo, diagnóstico ni tratamiento médico profesional. Los rangos de referencia pueden variar entre laboratorios. Consulta siempre a tu profesional sanitario para interpretar tus resultados concretos.